Corbus数据公布后股价暴涨,截止发帖时间已经上涨3倍多。
近日,石药集团/Corbus在2024年(ASCO-GU2024)上,公布了靶向nectin-4抗体药物偶联物(ADC)SYS6002的I期剂量递增数据。
具体数据可以查询Corbus发布的公告...查看全文
牛唐2023-03-17 17:31
医药板块速评(2023.03.16)
1、大盘反弹,是继续看多,还是做空良机?
2、$Corbus制药控股(CRBP)、$Elevation Oncology(ELEV)三天翻倍,背后逻辑是什么,谁有潜力成为下一个?
3、$中概互联网指数ETF-KraneShares(KWEB)、$英特尔(INTC)$ 、$台积电(TSM)期权大量成交,后续走势如何看...查看全文
chuminhua2021-06-27 22:45
6月25日,对于Corbus制药公司和自身免疫性疾病治疗药物lenabasum来说,情况并不乐观。
Corbus公司披露了这种合成口服大麻素2型激动剂的一长串失败案例,这次是在罕见的自身免疫性疾病皮肌炎的后期试验中。
早在9月,Corbus公司透露,lenabasum在皮肤系统性硬化症的3期试验中失败,另一项中...查看全文
andrewmed2021-04-21 09:22
文章来源:“凯莱英药闻”微信公众号
4月20日,瑞士创新药企业Synendos Therapeutics宣布延长A轮融资,新加入投资方Ysios Capital,将融资规模扩大至2400万瑞郎。Synendos于2020年11月开启A轮融资,由Kurma Partners和Sunstone Life Science Ventures共同投资,规模为2000万瑞郎。
该笔融...查看全文
$CORBUS PHARMACEUTICALS HLDGS(CRBP)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2016-03-28 AccNo: 0001564590-16-015407 Size: 118 KB 网页链接
$CORBUS PHARMACEUTICALS HLDGS(CRBP)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2016-03-28 AccNo: 0001564590-16-015403 Size: 6 MB 网页链接
$CORBUS PHARMACEUTICALS HLDGS(CRBP)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2016-03-01 AccNo: 0001144204-16-085246 Size: 92 KB 网页链接
$CORBUS PHARMACEUTICALS HLDGS(CRBP)$ 8-K - Current report Filed: 2016-01-11 AccNo: 0001564590-16-011792 Size: 13 MBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem ...
$CORBUS PHARMACEUTICALS HLDGS(CRBP)$ UPLOAD [Cover] - SEC-generated letter Filed: 2015-11-18 AccNo: 0000000000-15-054612 Size: 155 KB 网页链接
$CORBUS PHARMACEUTICALS HLDGS(CRBP)$ CORRESP [Cover] - Correspondence Filed: 2015-11-18 AccNo: 0001193125-15-380820 Size: 7 KB 网页链接
$CORBUS PHARMACEUTICALS HLDGS(CRBP)$ EFFECT - Notice of Effectiveness Filed: 2015-11-19 AccNo: 9999999995-15-003100 Size: 1 KB 网页链接
$CORBUS PHARMACEUTICALS HLDGS(CRBP)$ 8-K - Current report Filed: 2015-11-12 AccNo: 0001193125-15-374676 Size: 79 KBItem 2.02: Results of Operations and Financial ConditionItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$CORBUS PHARMACEUTICALS HLDGS(CRBP)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2015-11-10 AccNo: 0001193125-15-373638 Size: 833 KB 网页链接
$CORBUS PHARMACEUTICALS HLDGS(CRBP)$ 424B3 - Prospectus [Rule 424(b)(3)] Filed: 2015-11-10 AccNo: 0001193125-15-373624 Size: 1 MB 网页链接